GDR.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 17:29):

Stats
Dagens volum	1.27M
Gjennomsnittsvolum	3.21M
Markedsverdi	8.05M
EPS	£0 ( 2024-04-04 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.070
ATR14	£0.0870 (1.62%)

Volum Korrelasjon

Lang: -0.06 (neutral)

Kort: 0.51 (weak)

Signal:(46.936) Neutral

Genedrive PLC Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Genedrive PLC Korrelasjon - Valuta/Råvare

-0.31
( neutral )

-0.33
( neutral )

0.00
( neutral )

-0.40
( neutral )

-0.08
( neutral )

0.12
( neutral )

Genedrive PLC Økonomi

Annual	2022
Omsetning:	£55 000.00
Bruttogevinst:	£-199 000 (-361.82 %)
EPS:	£-0.0547

FY	2022
Omsetning:	£55 000.00
Bruttogevinst:	£-199 000 (-361.82 %)
EPS:	£-0.0547

FY	2022
Omsetning:	£49 000.00
Bruttogevinst:	£49 000.00 (100.00 %)
EPS:	£-0.0551

FY	2021
Omsetning:	£687 000
Bruttogevinst:	£0.00 (0.00 %)
EPS:	£-0.0265

Financial Reports:

No articles found.

Genedrive PLC

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small polymerase chain reaction, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for the rapid determination of military biothreats from pathogens; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.